cartitude-1: final results of ciltacabtagene autoleucel in heavily pretreated relapsed refractory mm
Published 1 year ago • 346 plays • Length 9:03Download video MP4
Download video MP3
Similar videos
-
4:25
updated results from cartitude-1: phase 1b/2study of cilta-cel in pts with rr multiple myeloma
-
2:23
ciltacabtagene autoleucel in rrmm: updated results from cartitude-1
-
3:52
updated results (2 years post-lpi) in phase 1b/2 (cartitude-1) study of cilta-cel in rrmm patients
-
2:32
final results of cartitude-1: cilta-cel in heavily pretreated patients with r/r multiple myeloma
-
2:25
cartitude-1 final results: cilta-cel in heavily pretreated patients with r/r myeloma
-
5:42
ciltacabtagene autoleucel in cartitude-1 vs standard of care in triple-class exposed mm pts
-
1:38
cartitude-1 final results: pfs of cilta-cel in patients with heavily pre-treated r/r myeloma
-
5:42
comparison of outcomes with cilta-cel in cartitude-1 vs rw soc for pts w/ triple-class exposed rrmm
-
5:46
outcomes from the cartitude-1 study assessing car t-cell therapy in rr multiple myeloma
-
3:54
update of cartitude-1: a phase ib/ii study of jnj-4528, a bcma-directed car-t-cell therapy, in rrmm
-
4:28
comparison of cartitude-1 outcomes vs real world clinical practice observed in german registry
-
3:28
cartitude-1: a phase 1b/2 study of jnj-4528, a car-t cell therapy directed against bcma
-
1:30
cartitude-1: promising initial results of cilta-cel for myeloma
-
5:44
cilta-cel in r/r myeloma: preliminary results from cartitude-1
-
5:53
saad usmani: updated results from the cartitude-1 trial in patients with heavily pretreated myeloma
-
4:23
ciltacabtagene autoleucel vs belantamab mafodotin in rrmm pts with ≥3 lines of prior therapy
-
8:34
results from cartitude-1: a phase 1b/2 study of jnj-4528, a car-t cell therapy directed against ...
-
5:16
idecabtagene vicleucel in pts with relapsed and refractory multiple myeloma: updated karmma results
-
2:15
comparison of patient-reported outcomes from cartitude-1 and locommotion